Key Points
Question What is the efficacy of 15 days of nirmatrelvir-ritonavir for improving select symptoms of postacute sequelae of SARS-CoV-2 infection (PASC)?
Findings This randomized clinical trial including 155 participants with PASC symptoms (≥3 months’ duration) found that a 15-day...
